Protease Inhibitor May Aid In Diabetic Retinopathy Treatment

Saturday, January 24, 2009 - 18:21 in Health & Medicine

Researchers have demonstrated that a specific inhibitor of the protease plasma kallikrein, ASP-440 may provide a new therapeutic approach for treatment of diabetic retinopathy, the most common eye-related complication of diabetes.

Read the whole article on Science Daily

More from Science Daily

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net